Clinical Trials

    Showing 1 - 9 of 9 Coronary Artery Disease

    Status: Enrolling

    Investigator: Alpesh Shah

    Study Coordinator: Sejal Dave

    Phone: 281.654.5383

    AGENT DCB STANCE is a prospective, multicenter, open-label, 1:1 randomized controlled study designed to assess the safety and effectiveness of a treatment strategy with the AGENT Drug-Coated Balloon compared to standard of care percutaneous coronary ... Read more >

    Status: Enrolling

    Investigator: Alpesh Shah

    Study Coordinator: Padmaja Naik

    Phone: 713.441.7386

    To demonstrate the safety and effectiveness of the Reducer system for treatment of patients with refractory angina pectoris treated with maximally tolerated guideline-directed medical therapy who demonstrate objective evidence of reversible myocardia... Read more >

    Status: Enrolling

    Investigator: Sadeer Al-Kindi

    Study Coordinator: Jad Ardakani

    Phone: 832.879.9810

    Observational study to evaluate factors associated with the absence of coronary plaque in individuals with cardiovascular risk factors. The study is employing a comprehensive approach, including coronary CTA, abdominal non-contrast CT, and detailed ... Read more >

    Status: Open Not Enrolling

    Investigator: Alpesh Shah

    Study Coordinator: Iris Alanis

    Phone: 713.441.6548

    The purpose of this study is to determine whether Fractional flow reserve (FFR, (coronary pressure wire-based index for assessing the ischemic potential of a coronary lesion)-guided percutaneous coronary intervention (PCI) in patients with multivesse... Read more >

    Status: Enrolling

    Investigator: Alpesh Shah

    Study Coordinator: Padmaja Naik

    Phone: 713.441.7386

    The FORWARD CAD IDE Study is a Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study conducted to assess the safety and effectiveness of the Shockwave Intravascular Lithotripsy (IVL) System with the Javelin Coronary IVL C... Read more >

    Status: Enrolling

    Investigator: Mouaz Al-Mallah

    Study Coordinator: Ahmad El Yaman

    Phone: 346.475.2849

    This retrospective cohort secondary data analysis aims to evaluate the diagnostic and prognostic utility of positron emission tomography (PET) using the flurpiridaz F-18 (FPZ) radiotracer in patients with known or suspected cardiovascular disease (CV... Read more >

    Status: Enrolling

    Investigator: Khurram Nasir

    Study Coordinator: Hira Saleem

    Phone: 346.238.0307

    In this comparative effectiveness trial, the aim of this study is to answer the research question of whether a remote blood pressure (BP) management program (RBPM, inclusive of home BP monitoring and telehealth visits with a nurse or pharmacist) alon... Read more >

    Status: Open Not Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Tia McGaughy

    Phone: 346.238.4576

    The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Ao... Read more >

    Status: Enrolling

    Investigator: Sachin Goel

    Study Coordinator: Deena Victor

    Phone: 713.441.4536

    Brief Summary: To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allow... Read more >